Document is current
Any future updates will be listed below
-
Authors
Veghini, Lisa
Pasini, Davide
Fang, Rui
Delfino, Pietro
Filippini, Dea
Neander, Christian
Vicentini, Caterina
Fiorini, Elena
Lupo, Francesca
D’Agosto, Sabrina L.
Carbone, Carmine https://orcid.org/0000-0001-5168-747X
Agostini, Antonio
Piro, Geny
Rosa, Diego
Bevere, Michele
Markus, Peter
Behrens, Diana
Luchini, Claudio https://orcid.org/0000-0003-4901-4908
Lawlor, Rita T. https://orcid.org/0000-0003-3160-0634
Scarpa, Aldo https://orcid.org/0000-0003-1678-739X
Biffi, Giulia https://orcid.org/0000-0003-4592-0970
Cheung, Phyllis F.
Siveke, Jens T. https://orcid.org/0000-0002-8772-4778
Corbo, Vincenzo https://orcid.org/0000-0002-6340-8009
- License Information
-
More Information
Article History
Received: 16 October 2023
Accepted: 26 November 2024
First Online: 3 December 2024
Competing interests
: J.S. receives honoraria as consultant or for continuing medical education presentations from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Immunocore, MSD Sharp Dohme, Novartis, Roche/Genentech and Servier. His institution receives research funding from Abalos Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eisbach Bio and Roche/Genentech; he holds ownership in FAPI Holding (<3%), all outside the submitted work. The other authors declare no competing interests.
